中企IPO
Search documents
2025年Q3共69家中企境内外IPO,募集资金共计1026.27亿元人民币丨睿兽分析IPO季报
Sou Hu Cai Jing· 2025-11-20 06:28
Core Insights - The number of Chinese company IPOs in Q3 2025 shows a year-on-year increase of 32.69% compared to Q3 2024, and a quarter-on-quarter increase of 2.99% from Q2 2025 [1] - A-shares remain the primary market for IPOs, with 27 companies listed in both Q1 and Q3 2025, while Hong Kong's IPO numbers fluctuate but have a significantly higher fundraising amount, exceeding A-shares by 72.91% [2] Market Overview - In Q3 2025, A-shares had the highest IPO activity with 27 companies, while Hong Kong had 24 companies, and the US market maintained a stable number of listings [1] - The overall trend for Hong Kong IPOs shows a pattern of "peaking and maintaining a high level" [1] Industry Distribution - Among the 69 companies that went public in Q3 2025, the healthcare and traditional industries each had 9 IPOs, accounting for 26.09% of the total [7] - The top five industries by fundraising scale were traditional industry (25.64 billion RMB), automotive transportation (21.38 billion RMB), energy and electricity (18.85 billion RMB), materials (8.14 billion RMB), and intelligent manufacturing (7.98 billion RMB) [7] Regional Distribution - In Q3 2025, Hong Kong led with 15 IPOs raising 27.68 billion RMB, followed by Jiangsu with 12 IPOs raising 9.88 billion RMB, and Guangdong with 10 IPOs raising 8.30 billion RMB [7] Investment Insights - Out of the 69 IPO companies, 34 had received prior investments, resulting in an institutional penetration rate of 49.28% [14] - In A-shares, 15 out of 27 companies had prior investments, with a penetration rate of 55.56% [18] - In Hong Kong, 18 out of 24 companies had prior investments, leading to a penetration rate of 75.00% [18]
2025年H1共137家中企境内外IPO,募集资金共计1311.36亿元人民币丨睿兽分析IPO半年报
创业邦· 2025-07-26 01:02
Overall Overview - In the first half of 2025, the number of Chinese companies going public (IPO) decreased to 137, a decline of 56.78% compared to 317 in the first half of 2021, but an increase of 37.00% from 100 in the first half of 2024 [3] - The proportion of companies listed in Hong Kong and the United States increased, with Hong Kong accounting for 29.93% and the U.S. for 32.85% of the total [3] - Among the 137 companies that went public, 51 were listed on the A-share market, 41 on the Hong Kong market, and 45 on the U.S. market. The total fundraising amounts were 37.065 billion RMB for A-shares, 87.798 billion RMB for Hong Kong, and 6.273 billion RMB for U.S. markets [3] Industry/Region Distribution Overview - Among the 137 companies that completed IPOs in the first half of 2025, traditional industries were prominent with 29 companies, accounting for 21.17% of the total. Other notable sectors included healthcare (14 companies), consumer goods (14 companies), smart manufacturing (13 companies), and automotive transportation (13 companies) [7] - The top five industries by fundraising scale were energy and power (34.742 billion RMB), consumer goods (20.220 billion RMB), healthcare (15.453 billion RMB), smart manufacturing (14.446 billion RMB), and traditional industries (13.228 billion RMB) [7] - In terms of regional distribution, Zhejiang led with 25 companies, representing 18.25% of the national total. Other regions included Jiangsu (21 companies), Hong Kong (19 companies), and Guangdong (16 companies). Fujian had the highest fundraising amount at 33.416 billion RMB, followed by Zhejiang (25.124 billion RMB), Jiangsu (18.514 billion RMB), and Guangdong (17.912 billion RMB) [7] Institutional Performance Overview - Out of the 137 companies that went public, 77 had received prior investments, resulting in an institutional penetration rate of 56.20%. Among these, 75 had received VC/PE investments and 38 had received CVC investments, with penetration rates of 54.74% and 27.74% respectively [14] - In the A-share market, 38 out of 51 companies had received prior investments, leading to a penetration rate of 74.51%. This included 37 companies with VC/PE investments and 19 with CVC investments, with respective penetration rates of 72.55% and 37.25% [16] - In the Hong Kong market, 30 out of 41 companies had received prior investments, resulting in a penetration rate of 73.17%. This included 29 companies with VC/PE investments and 15 with CVC investments, with penetration rates of 70.73% and 36.59% respectively [16] - In the U.S. market, only 9 out of 45 companies had received prior investments, leading to a penetration rate of 20.00%. All 9 had received VC/PE investments, and 4 had received CVC investments, with respective penetration rates of 20.00% and 8.89% [16]
2025年Q1共64家中企境内外IPO,同比增加18.52%;募集资金共计342.81亿元人民币丨睿兽分析IPO季报
创业邦· 2025-05-03 00:53
Core Insights - The article discusses the IPO performance of Chinese companies in Q1 2025, highlighting a total of 64 IPOs, which represents an increase of 18.52% compared to Q1 2024, but a decrease of 17.95% from Q4 2024 [3]. IPO Overview - In Q1 2025, 64 Chinese companies went public, with 27 on A-shares, 15 on Hong Kong stocks, and 22 on US stocks [3]. - The total fundraising amounts were 16.276 billion RMB for A-shares, 15.980 billion RMB for Hong Kong stocks, and 2.026 billion RMB for US stocks [3]. Industry Distribution - Among the 64 IPOs, traditional industries led with 14 companies (21.88%), followed by healthcare (7), automotive (6), smart manufacturing (5), and materials (5) [7]. - The top five industries by fundraising were traditional industries (8.342 billion RMB), consumer (4.927 billion RMB), materials (4.347 billion RMB), healthcare (2.886 billion RMB), and automotive (2.426 billion RMB) [7]. - The consumer sector saw significant fundraising due to the IPO of the ice cream tea brand Mixue Ice Cream (HK:02097), which raised 3.208 billion RMB [7]. Regional Distribution - Zhejiang province led with 12 IPOs (6.921 billion RMB), accounting for 18.75% of the total [7]. - Hong Kong and Jiangsu both had 9 IPOs, raising 3.433 billion RMB and 3.208 billion RMB, respectively [7]. Unicorn Companies - Two unicorns were among the IPOs: Mixue Ice Cream and Weisheng Pharmaceutical, the latter focusing on endocrine treatment solutions [8]. Institutional Investment - Out of the 64 companies, 32 had received prior investment, resulting in an institutional penetration rate of 50% [15]. - In A-shares, 19 out of 27 companies had prior investments, with a penetration rate of 70.37% [15]. - For Hong Kong stocks, 8 out of 15 companies had prior investments, yielding a penetration rate of 53.33% [15]. - In US stocks, only 5 out of 22 companies had prior investments, with a penetration rate of 22.73% [17].